The effects of dorzolamide nanoliposome in open angle glaucoma
Phase 1
- Conditions
- primary open-angle glaucoma.primary open-angle glaucoma
- Registration Number
- IRCT2016020426360N1
- Lead Sponsor
- Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients must use only one drug to reduce their intraocular pressure.
Exclusion criteria: patients that have hypertension, diabetes , autoimune disease or chronic disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure. Timepoint: before intervention, in middle(Day 14th and Day 28th) and in long term(Day 42th and Day 56th). Method of measurement: Goldmann applanation tonometry.
- Secondary Outcome Measures
Name Time Method Adverse effects. Timepoint: Days 14? 28? 42 and 56. Method of measurement: patient complaint.